Mes: abril 2020

Actualización del coronavirus (COVID-19): Juez federal emite una orden temporal en contra de Genesis II Church of Health and Healing que previene la venta de productos de cloro dióxido para tratar el COVID-19 equivalentes al blanqueador industrial

La agencia continúa sus esfuerzos para proteger la salud pública de productos fraudulentos y potencialmente nocivos

In English

SILVER SPRING, Maryland, 21 de abril de 2020 /PRNewswire-HISPANIC PR WIRE/…

La agencia continúa sus esfuerzos para proteger la salud pública de productos fraudulentos y potencialmente nocivos

In English

SILVER SPRING, Maryland, 21 de abril de 2020 /PRNewswire-HISPANIC PR WIRE/ — Un tribunal federal ha emitido una orden temporal en contra de Genesis II Church of Health and Healing (Genesis) y cuatro individuos asociados con la entidad requiriéndoles que paren inmediatamente de distribuir su «Miracle Mineral Solution (Solución Mineral Milagrosa o MMS), un tratamiento no probado y potencialmente dañino que Genesis está ofreciendo para la venta para tratar los coronavirus, incluyendo la enfermedad del Coronavirus 2019 (COVID-19) y muchas otras enfermedades. Al acceder a la solicitud de ayuda del gobierno, el tribunal determinó que los Estados Unidos han demostrado que Genesis y los individuos asociados nombrados en la orden están violando la Ley Federal de Alimentos, Medicamentos y Cosméticos (FD&C, por sus siglas en inglés) al distribuir ilegalmente MMS, un nuevo medicamento no aprobado y un medicamento mal etiquetado. Cuando se combina con el activador incluido, el MMS tiene un contenido de cloro dióxido equivalente al blanqueador industrial. El tribunal también determinó que existe lriesgo de que los demandados continúen violando la ley si no hay una orden de restricción temporal en vigor.

«Los estadounidenses esperan y merecen tratamientos médicos probados y la medida tomada hoy es un recordatorio poderoso que la FDA ejercerá sus poderes legales para detener rápidamente a aquellos que continúan amenazando la salud del público estadounidense. Es vital que los comerciantes de productos farmacológicos cumplan con la Ley FD&C y que no vendan productos con afirmaciones falsas y engañosas, especialmente para tratar el COVID-19 y otras enfermedades debilitantes, tales como el autismo y la enfermedad de Alzheimer», dijo el comisionado de la FDA, el Dr. Stephen M. Hahn, M.D. «A pesar de haber recibido una advertencia previa, Genesis II Church of Healing ha seguido de forma activa poniendo en peligro a los consumidores al vender productos de cloro dióxido que no han sido aprobados y que son posiblemente peligrosos.  No vamos a permitir esto, y la FDA se mantiene completamente comprometida a tomar fuertes medidas de ejecución en contra de cualquier comerciante que ponga en riesgo a los consumidores estadounidenses crédulos al ofrecer sus productos no probados para tratar enfermedades serias».

La FDA, conjuntamente con la Comisión Federal de Comercio (FTC, por sus siglas en inglés), emitió previamente una carta de advertencia  a Genesis, y la FDA ha advertido a los consumidores en numerosas ocasiones durante la última década que no compren o tomen productos de cloro dióxido, tales como el MMS, que se venden como tratamientos médicos. La FDA y la FTC le pidieron a la compañía que respondiera dentro de 48 horas, con una descripción de las medidas específicas que han tomado para corregir las violaciones. En su respuesta a la carta de advertencia, los demandados estuvieron muy claros que no tienen la intención de tomar medidas correctivas y que continuarán vendiendo el MMS en violación a la ley. Esto es de gran preocupación para la agencia ya que la FDA ha recibido reportes de personas que han experimentado serios eventos adversos, incluyendo fallo respiratorio, presión sanguínea muy baja y potencialmente mortal, insuficiencia hepática aguda, y prolongación del QT (trastorno del ritmo cardíaco), despus de tomar ciertos productos de cloro dióxido. 

La FDA no ha aprobado el producto de Genesis para ningún uso, a pesar de que los demandados afirman que estos productos pueden usarse para curar, aliviar o prevenir enfermedades como el COVID-19, la enfermedad de Alzheimer, el autismo, el cáncer de cerebro, la esclerosis múltiple y el VIH/SIDA. Las afirmaciones en el sitio web de Genesis, el cual proporciona un enlace para comprar el MMS, incluyen, «El Coronavirus es curable, ¿usted cree esto? . . . MMS lo puede matar».  La agencia no conoce de ninguna evidencia científica que apoya la seguridad o eficacia del MMS para tratar una enfermedad, y no existe una solicitud de medicamento aprobado en vigor para el MMS que haya sido presentada por los demandados. 

Como consecuencia de estas violaciones, la jueza de Distrito de los EE.UU. Kathleen M. Williams del Tribunal de Distrito del Sur de Florida, emitió hoy la orden de restricción temporal en contra de Genesis y los individuos demandados Mark Grenon, Joseph Grenon, Jordan Grenon y Jonathan Grenon hasta el 1 de mayo de 2020. Una audiencia tendrá lugar el 1 de mayo de 2020 con respecto a la solicitud del gobierno de extender la orden. La denuncia, presentada por el Departamento de Justicia de los EE.UU. (DOJ, por sus siglas en inglés), en contra del comerciante en Bradenton, Fla. y los individuos vendedores más responsables, solicita restringir y prohibir que los demandados etiqueten, almacenen y distribuyan nuevos medicamentos no probados y medicamentos mal etiquetados, incluyendo el MMS, en el comercio interestatal de forma permanente. La FDA le solicitó al DOJ que inicie el caso en nombre del Gobierno de los EE.UU.  Las afirmaciones incluidas en la denuncia son alegatos que, si el caso procede a juicio, el gobierno debe probar para recibir una orden permanente en contra de Genesis. 

La FDA se preocupa especialmente de que los productos que afirman curar, tratar o prevenir enfermedades graves, como el COVID-19, pueden causar que los consumidores retrasen o detengan un tratamiento médico apropiado, resultando en daños graves y mortales. Actualmente no existen vacunas o medicamentos que hayan sido aprobados para tratar o prevenir el COVID-19. La FDA le recuerda al público que busque ayuda médica de sus proveedores de atención médica. Además, los niños son una población vulnerable que puede correr un mayor riesgo de experimentar reacciones adversas por consumir productos de cloro dióxido. La FDA alienta a los profesionales de atención médica y a los consumidores que reporten eventos adversos o problemas de calidad que experimenten con el uso de productos para el COVID-19 al programa de la FDA: Programa de informes de eventos adversos de MedWatch.

La FDA sigue monitoreado las redes sociales, los mercados en línea y las quejas recibidas para ayudar a asegurar que los comerciantes no continúen vendiendo productos fraudulentos relacionados con el COVID-19. 

Para más información consulte:

La FDA, una agencia que es parte del Departamento de Salud y Servicios Humanos de los EE.UU., protege la salud pública al asegurar la seguridad, eficacia y protección de los medicamentos humanos y veterinarios, vacunas y otros productos biológicos para el uso humano, y los dispositivos médicos. La agencia también es responsable de la seguridad del suministro de alimentos, cosméticos, suplementos alimenticios, y de los productos que emiten radiación electrónica de nuestra nación, y de regular los productos de tabaco.

Información para los medios de comunicación: Gloria Sánchez-Contreras, 301-796-7686, gloria.sanchez-contreras@fda.hhs.gov 
Información al consumidor: 888-INFO-FDA
www.FDA.gov/Espanol

U.S. Food and Drug Administration

Logo – https://mma.prnewswire.com/media/317925/FDA_Logo.jpg

FUENTE U.S. Food and Drug Administration

Actualización del coronavirus (COVID-19): Juez federal emite una orden temporal en contra de Genesis II Church of Health and Healing que previene la venta de productos de cloro dióxido para tratar el COVID-19 equivalentes al blanqueador industrial

La agencia continúa sus esfuerzos para proteger la salud pública de productos fraudulentos y potencialmente nocivos

In English

SILVER SPRING, Maryland, 21 de abril de 2020 /PRNewswire-HISPANIC PR WIRE/…

La agencia continúa sus esfuerzos para proteger la salud pública de productos fraudulentos y potencialmente nocivos

In English

SILVER SPRING, Maryland, 21 de abril de 2020 /PRNewswire-HISPANIC PR WIRE/ — Un tribunal federal ha emitido una orden temporal en contra de Genesis II Church of Health and Healing (Genesis) y cuatro individuos asociados con la entidad requiriéndoles que paren inmediatamente de distribuir su «Miracle Mineral Solution (Solución Mineral Milagrosa o MMS), un tratamiento no probado y potencialmente dañino que Genesis está ofreciendo para la venta para tratar los coronavirus, incluyendo la enfermedad del Coronavirus 2019 (COVID-19) y muchas otras enfermedades. Al acceder a la solicitud de ayuda del gobierno, el tribunal determinó que los Estados Unidos han demostrado que Genesis y los individuos asociados nombrados en la orden están violando la Ley Federal de Alimentos, Medicamentos y Cosméticos (FD&C, por sus siglas en inglés) al distribuir ilegalmente MMS, un nuevo medicamento no aprobado y un medicamento mal etiquetado. Cuando se combina con el activador incluido, el MMS tiene un contenido de cloro dióxido equivalente al blanqueador industrial. El tribunal también determinó que existe lriesgo de que los demandados continúen violando la ley si no hay una orden de restricción temporal en vigor.

«Los estadounidenses esperan y merecen tratamientos médicos probados y la medida tomada hoy es un recordatorio poderoso que la FDA ejercerá sus poderes legales para detener rápidamente a aquellos que continúan amenazando la salud del público estadounidense. Es vital que los comerciantes de productos farmacológicos cumplan con la Ley FD&C y que no vendan productos con afirmaciones falsas y engañosas, especialmente para tratar el COVID-19 y otras enfermedades debilitantes, tales como el autismo y la enfermedad de Alzheimer», dijo el comisionado de la FDA, el Dr. Stephen M. Hahn, M.D. «A pesar de haber recibido una advertencia previa, Genesis II Church of Healing ha seguido de forma activa poniendo en peligro a los consumidores al vender productos de cloro dióxido que no han sido aprobados y que son posiblemente peligrosos.  No vamos a permitir esto, y la FDA se mantiene completamente comprometida a tomar fuertes medidas de ejecución en contra de cualquier comerciante que ponga en riesgo a los consumidores estadounidenses crédulos al ofrecer sus productos no probados para tratar enfermedades serias».

La FDA, conjuntamente con la Comisión Federal de Comercio (FTC, por sus siglas en inglés), emitió previamente una carta de advertencia  a Genesis, y la FDA ha advertido a los consumidores en numerosas ocasiones durante la última década que no compren o tomen productos de cloro dióxido, tales como el MMS, que se venden como tratamientos médicos. La FDA y la FTC le pidieron a la compañía que respondiera dentro de 48 horas, con una descripción de las medidas específicas que han tomado para corregir las violaciones. En su respuesta a la carta de advertencia, los demandados estuvieron muy claros que no tienen la intención de tomar medidas correctivas y que continuarán vendiendo el MMS en violación a la ley. Esto es de gran preocupación para la agencia ya que la FDA ha recibido reportes de personas que han experimentado serios eventos adversos, incluyendo fallo respiratorio, presión sanguínea muy baja y potencialmente mortal, insuficiencia hepática aguda, y prolongación del QT (trastorno del ritmo cardíaco), despus de tomar ciertos productos de cloro dióxido. 

La FDA no ha aprobado el producto de Genesis para ningún uso, a pesar de que los demandados afirman que estos productos pueden usarse para curar, aliviar o prevenir enfermedades como el COVID-19, la enfermedad de Alzheimer, el autismo, el cáncer de cerebro, la esclerosis múltiple y el VIH/SIDA. Las afirmaciones en el sitio web de Genesis, el cual proporciona un enlace para comprar el MMS, incluyen, «El Coronavirus es curable, ¿usted cree esto? . . . MMS lo puede matar».  La agencia no conoce de ninguna evidencia científica que apoya la seguridad o eficacia del MMS para tratar una enfermedad, y no existe una solicitud de medicamento aprobado en vigor para el MMS que haya sido presentada por los demandados. 

Como consecuencia de estas violaciones, la jueza de Distrito de los EE.UU. Kathleen M. Williams del Tribunal de Distrito del Sur de Florida, emitió hoy la orden de restricción temporal en contra de Genesis y los individuos demandados Mark Grenon, Joseph Grenon, Jordan Grenon y Jonathan Grenon hasta el 1 de mayo de 2020. Una audiencia tendrá lugar el 1 de mayo de 2020 con respecto a la solicitud del gobierno de extender la orden. La denuncia, presentada por el Departamento de Justicia de los EE.UU. (DOJ, por sus siglas en inglés), en contra del comerciante en Bradenton, Fla. y los individuos vendedores más responsables, solicita restringir y prohibir que los demandados etiqueten, almacenen y distribuyan nuevos medicamentos no probados y medicamentos mal etiquetados, incluyendo el MMS, en el comercio interestatal de forma permanente. La FDA le solicitó al DOJ que inicie el caso en nombre del Gobierno de los EE.UU.  Las afirmaciones incluidas en la denuncia son alegatos que, si el caso procede a juicio, el gobierno debe probar para recibir una orden permanente en contra de Genesis. 

La FDA se preocupa especialmente de que los productos que afirman curar, tratar o prevenir enfermedades graves, como el COVID-19, pueden causar que los consumidores retrasen o detengan un tratamiento médico apropiado, resultando en daños graves y mortales. Actualmente no existen vacunas o medicamentos que hayan sido aprobados para tratar o prevenir el COVID-19. La FDA le recuerda al público que busque ayuda médica de sus proveedores de atención médica. Además, los niños son una población vulnerable que puede correr un mayor riesgo de experimentar reacciones adversas por consumir productos de cloro dióxido. La FDA alienta a los profesionales de atención médica y a los consumidores que reporten eventos adversos o problemas de calidad que experimenten con el uso de productos para el COVID-19 al programa de la FDA: Programa de informes de eventos adversos de MedWatch.

La FDA sigue monitoreado las redes sociales, los mercados en línea y las quejas recibidas para ayudar a asegurar que los comerciantes no continúen vendiendo productos fraudulentos relacionados con el COVID-19. 

Para más información consulte:

La FDA, una agencia que es parte del Departamento de Salud y Servicios Humanos de los EE.UU., protege la salud pública al asegurar la seguridad, eficacia y protección de los medicamentos humanos y veterinarios, vacunas y otros productos biológicos para el uso humano, y los dispositivos médicos. La agencia también es responsable de la seguridad del suministro de alimentos, cosméticos, suplementos alimenticios, y de los productos que emiten radiación electrónica de nuestra nación, y de regular los productos de tabaco.

Información para los medios de comunicación: Gloria Sánchez-Contreras, 301-796-7686, gloria.sanchez-contreras@fda.hhs.gov 
Información al consumidor: 888-INFO-FDA
www.FDA.gov/Espanol

U.S. Food and Drug Administration

Logo – https://mma.prnewswire.com/media/317925/FDA_Logo.jpg

FUENTE U.S. Food and Drug Administration

Coronavirus (COVID-19) Update: Federal judge enters temporary injunction against Genesis II Church of Health and Healing, preventing sale of Chlorine Dioxide Products Equivalent to Industrial Bleach to Treat COVID-19

SILVER SPRING, Maryland, April 17, 2020 /PRNewswire-HISPANIC PR WIRE/ — A federal court has entered a temporary injunction against the Genesis II Church of Health and Healing (Genesis) and four individuals associated with the entity requiring them to immediately stop distributing its «Miracle Mineral Solution» (MMS), an unproven and potentially harmful treatment offered for sale to treat Coronavirus, which includes Coronavirus Disease 2019 (COVID-19) and many other diseases. In granting the…

SILVER SPRING, Maryland, April 17, 2020 /PRNewswire-HISPANIC PR WIRE/ — A federal court has entered a temporary injunction against the Genesis II Church of Health and Healing (Genesis) and four individuals associated with the entity requiring them to immediately stop distributing its «Miracle Mineral Solution» (MMS), an unproven and potentially harmful treatment offered for sale to treat Coronavirus, which includes Coronavirus Disease 2019 (COVID-19) and many other diseases. In granting the government’s request for relief, the court found that the United States has demonstrated that Genesis and the associated individuals named in the injunction are violating the Federal Food, Drug, and Cosmetic Act (FD&C) by unlawfully distributing MMS, an unapproved new drug and misbranded drug. When combined with the included activator MMS has a chlorine dioxide content equivalent to industrial bleach. The court also found that there is a danger that the defendants will continue violating the law without the temporary restraining order.

«Americans expect and deserve proven medical treatments and today’s action is a forceful reminder that the FDA will use its legal authorities to quickly stop those who have proven to continuously threaten the health of the American public. It is vital that sellers of drug products comply with the FD&C Act and do not sell products with false and misleading claims, especially to treat COVID-19 and other debilitating diseases, such as autism and Alzheimer’s Disease,» said FDA Commissioner Stephen M. Hahn, M.D. «Despite a previous warning, the Genesis II Church of Healing has continued to actively place consumers at risk by peddling potentially dangerous and unapproved chlorine dioxide products. We will not stand for this, and the FDA remains fully committed to taking strong enforcement action against any sellers who place unsuspecting American consumers at risk by offering their unproven products to treat serious diseases.»

The FDA, jointly with the Federal Trade Commission (FTC), previously issued a warning letter to Genesis and the FDA has warned consumers numerous times over the past decade not to purchase or drink chlorine dioxide products such as MMS sold as medical treatments. The FDA and FTC requested that the company respond within 48 hours describing the specific steps it has taken to correct the violations. In response to the warning letter, the defendants made clear that they had no intention of taking corrective action and would continue to sell MMS in violation of the law. This is especially concerning to the agency as the FDA has received reports of people experiencing serious adverse events, including respiratory failure, life-threatening low blood pressure, acute liver failure and QT prolongation after drinking certain chlorine dioxide products.

The FDA has not approved Genesis’s product for any use, despite the defendants’ claims that these products can be used to cure, mitigate, treat or prevent diseases such as COVID-19, Alzheimer’s, autism, brain cancer, multiple sclerosis and HIV/AIDS. Claims made on the Genesis websites, which provide a link to purchase MMS, include, «The Coronavirus is curable, you believe that? . . . MMS will kill it.» The agency is not aware of any scientific evidence supporting the safety or efficacy of MMS to treat any disease and there are no approved drug applications in effect for the defendants’ MMS.

As a result of these violations, today, U.S. District Judge Kathleen M. Williams for the U.S. District Court for the Southern District of Florida, entered the temporary restraining order against Genesis and the individual defendants Mark Grenon, Joseph Grenon, Jordan Grenon and Jonathan Grenon until May 1st, 2020. There will be a hearing on the government’s request to extend the injunction on May 1st, 2020. The complaint, filed by the U.S. Department of Justice (DOJ), against the Bradenton, Fla. seller and the seller’s most responsible individuals, seeks to restrain and enjoin all defendants from labeling, holding and distributing unapproved new drugs and misbranded drugs, including MMS, in interstate commerce on a permanent basis. The FDA requested the DOJ to bring this case on behalf of the U.S. Government. The claims made in the complaint are allegations that, if the case were to proceed to trial, the government must prove to receive a permanent injunction against Genesis.

The FDA is particularly concerned that products that claim to cure, treat or prevent serious diseases like COVID-19 may cause consumers to delay or stop appropriate medical treatment, leading to serious and life-threatening harm. There are currently no vaccines or drugs approved to treat or prevent COVID-19. The FDA reminds the public to seek medical help from their health care providers. Additionally, children are a vulnerable population that may be at greater risk for adverse reactions from consuming chlorine dioxide products. The FDA encourages health care professionals and consumers to report adverse events or quality problems experienced with the use of COVID-19 products to the FDA’s MedWatch Adverse Event Reporting program.

The FDA continues to monitor social media, online marketplaces and incoming complaints to help ensure that sellers do not continue to sell fraudulent products related to COVID-19.

Additional Resources:

Media Contact: Jeremy Kahn, 301-796-8671
Consumer Inquiries: Email or 888-INFO-FDA

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

This press release was updated as of 4/17/2020 to clarify that a preliminary injunction was not entered and to provide the date for the hearing on the preliminary injunction request.

U.S. Food and Drug Administration

Logo – https://mma.prnewswire.com/media/317925/FDA_Logo.jpg

SOURCE U.S. Food and Drug Administration

Coronavirus (COVID-19) Update: Federal judge enters temporary injunction against Genesis II Church of Health and Healing, preventing sale of Chlorine Dioxide Products Equivalent to Industrial Bleach to Treat COVID-19

SILVER SPRING, Maryland, April 17, 2020 /PRNewswire-HISPANIC PR WIRE/ — A federal court has entered a temporary injunction against the Genesis II Church of Health and Healing (Genesis) and four individuals associated with the entity requiring them to immediately stop distributing its «Miracle Mineral Solution» (MMS), an unproven and potentially harmful treatment offered for sale to treat Coronavirus, which includes Coronavirus Disease 2019 (COVID-19) and many other diseases. In granting the…

SILVER SPRING, Maryland, April 17, 2020 /PRNewswire-HISPANIC PR WIRE/ — A federal court has entered a temporary injunction against the Genesis II Church of Health and Healing (Genesis) and four individuals associated with the entity requiring them to immediately stop distributing its «Miracle Mineral Solution» (MMS), an unproven and potentially harmful treatment offered for sale to treat Coronavirus, which includes Coronavirus Disease 2019 (COVID-19) and many other diseases. In granting the government’s request for relief, the court found that the United States has demonstrated that Genesis and the associated individuals named in the injunction are violating the Federal Food, Drug, and Cosmetic Act (FD&C) by unlawfully distributing MMS, an unapproved new drug and misbranded drug. When combined with the included activator MMS has a chlorine dioxide content equivalent to industrial bleach. The court also found that there is a danger that the defendants will continue violating the law without the temporary restraining order.

«Americans expect and deserve proven medical treatments and today’s action is a forceful reminder that the FDA will use its legal authorities to quickly stop those who have proven to continuously threaten the health of the American public. It is vital that sellers of drug products comply with the FD&C Act and do not sell products with false and misleading claims, especially to treat COVID-19 and other debilitating diseases, such as autism and Alzheimer’s Disease,» said FDA Commissioner Stephen M. Hahn, M.D. «Despite a previous warning, the Genesis II Church of Healing has continued to actively place consumers at risk by peddling potentially dangerous and unapproved chlorine dioxide products. We will not stand for this, and the FDA remains fully committed to taking strong enforcement action against any sellers who place unsuspecting American consumers at risk by offering their unproven products to treat serious diseases.»

The FDA, jointly with the Federal Trade Commission (FTC), previously issued a warning letter to Genesis and the FDA has warned consumers numerous times over the past decade not to purchase or drink chlorine dioxide products such as MMS sold as medical treatments. The FDA and FTC requested that the company respond within 48 hours describing the specific steps it has taken to correct the violations. In response to the warning letter, the defendants made clear that they had no intention of taking corrective action and would continue to sell MMS in violation of the law. This is especially concerning to the agency as the FDA has received reports of people experiencing serious adverse events, including respiratory failure, life-threatening low blood pressure, acute liver failure and QT prolongation after drinking certain chlorine dioxide products.

The FDA has not approved Genesis’s product for any use, despite the defendants’ claims that these products can be used to cure, mitigate, treat or prevent diseases such as COVID-19, Alzheimer’s, autism, brain cancer, multiple sclerosis and HIV/AIDS. Claims made on the Genesis websites, which provide a link to purchase MMS, include, «The Coronavirus is curable, you believe that? . . . MMS will kill it.» The agency is not aware of any scientific evidence supporting the safety or efficacy of MMS to treat any disease and there are no approved drug applications in effect for the defendants’ MMS.

As a result of these violations, today, U.S. District Judge Kathleen M. Williams for the U.S. District Court for the Southern District of Florida, entered the temporary restraining order against Genesis and the individual defendants Mark Grenon, Joseph Grenon, Jordan Grenon and Jonathan Grenon until May 1st, 2020. There will be a hearing on the government’s request to extend the injunction on May 1st, 2020. The complaint, filed by the U.S. Department of Justice (DOJ), against the Bradenton, Fla. seller and the seller’s most responsible individuals, seeks to restrain and enjoin all defendants from labeling, holding and distributing unapproved new drugs and misbranded drugs, including MMS, in interstate commerce on a permanent basis. The FDA requested the DOJ to bring this case on behalf of the U.S. Government. The claims made in the complaint are allegations that, if the case were to proceed to trial, the government must prove to receive a permanent injunction against Genesis.

The FDA is particularly concerned that products that claim to cure, treat or prevent serious diseases like COVID-19 may cause consumers to delay or stop appropriate medical treatment, leading to serious and life-threatening harm. There are currently no vaccines or drugs approved to treat or prevent COVID-19. The FDA reminds the public to seek medical help from their health care providers. Additionally, children are a vulnerable population that may be at greater risk for adverse reactions from consuming chlorine dioxide products. The FDA encourages health care professionals and consumers to report adverse events or quality problems experienced with the use of COVID-19 products to the FDA’s MedWatch Adverse Event Reporting program.

The FDA continues to monitor social media, online marketplaces and incoming complaints to help ensure that sellers do not continue to sell fraudulent products related to COVID-19.

Additional Resources:

Media Contact: Jeremy Kahn, 301-796-8671
Consumer Inquiries: Email or 888-INFO-FDA

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

This press release was updated as of 4/17/2020 to clarify that a preliminary injunction was not entered and to provide the date for the hearing on the preliminary injunction request.

U.S. Food and Drug Administration

Logo – https://mma.prnewswire.com/media/317925/FDA_Logo.jpg

SOURCE U.S. Food and Drug Administration

The Home Depot to Hold Virtual Annual Meeting of Shareholders

ATLANTA, April 21, 2020 /PRNewswire-HISPANIC PR WIRE/ — The Home Depot®, the world’s largest home improvement retailer, today announced that it will hold its 2020 Annual Meeting of Shareholders virtually due to the public health impact of the COVID-19 pandemic and to support the health and well-being of its shareholders, associates, directors, and the community.

<img id="prnejpg8e19left" title="The Home…

ATLANTA, April 21, 2020 /PRNewswire-HISPANIC PR WIRE/ — The Home Depot®, the world’s largest home improvement retailer, today announced that it will hold its 2020 Annual Meeting of Shareholders virtually due to the public health impact of the COVID-19 pandemic and to support the health and well-being of its shareholders, associates, directors, and the community.

The Home Depot logo.

The Annual Meeting will be held on the same date and time as originally scheduled: Thursday, May 21, 2020 at 9:00 a.m., Eastern Time. Online access to the meeting will begin at 8:45 a.m., Eastern Time. Shareholders will not be able to attend the meeting in person. Any updates will be posted at https://ir.homedepot.com/shareholder-services/annual-meeting prior to the meeting date.

The Home Depot also announced that it plans to return to a physical, in-person meeting format next year for its 2021 Annual Meeting of Shareholders.

Attending the Virtual Annual Meeting

Shareholders of record as of the close of business on March 23, 2020, the record date, or «street name» holders that hold a legal proxy, broker’s proxy card or voting information form provided by their bank, broker or nominee, can attend the meeting by accessing www.virtualshareholdermeeting.com/HD2020 and entering the 16-digit control number included in the proxy materials previously received. Please note that the www.virtualshareholdermeeting.com/HD2020 web page will not be active until approximately two weeks before the meeting date.

Asking Questions

Shareholders may submit questions in two ways. If they wish to submit a question before the meeting, then beginning on April 22, 2020, until the meeting, they may log into www.proxyvote.com and enter their 16-digit control number. Once past the login screen, click on «Question for Management,» type in the question, and click «Submit.» Alternatively, shareholders will be able to submit questions live during the meeting by accessing the meeting at www.virtualshareholdermeeting.com/HD2020 using their 16-digit control number, typing the question into the «Ask a Question» field, and clicking submit.

Only questions pertinent to meeting matters will be answered during the meeting, subject to time constraints. Questions regarding personal matters, including those related to employment, product or service issues, or suggestions for product innovations, are not pertinent to meeting matters and therefore will not be answered. Questions that are substantially similar may be grouped and answered together to avoid repetition.

If we are unable to answer your question during the meeting due to time constraints, you are encouraged to contact The Home Depot Investor Relations department at investor_relations@homedepot.com.

Voting Shares at the Virtual Meeting

Shareholders who have not voted their shares prior to the meeting or who wish to change their vote will be able to vote their shares electronically at the meeting by clicking «Vote Here» on the meeting website.

Whether or not shareholders plan to attend the meeting, they are encouraged to vote their shares prior to the meeting by one of the methods described in the proxy materials previously provided. Shareholders may continue to use the proxy materials they previously received to vote their shares in connection with the meeting.

Shareholders who have already voted do not need to vote again.

Accessing the List of Shareholders Entitled to Vote

An electronic list of the shareholders of record as of the record date will be available for examination by shareholders at www.virtualshareholdermeeting.com/HD2020 during the meeting, along with the proxy materials for the meeting. Shareholders will need to enter their 16-digit control number to access the shareholder list. Information on how to access the list of shareholders from May 11, 2020 until the meeting is available at https://ir.homedepot.com/shareholder-services/annual-meeting.

Attending the Virtual Meeting as a Guest

If you do not have a 16-digit control number, you may still attend the meeting as a guest in listen-only mode. To attend as a guest, please access www.virtualshareholdermeeting.com/HD2020 and enter the information requested on the screen to register as a guest. Please note that you will not have the ability to ask questions, vote or examine the list of shareholders during the meeting if you participate as a guest.

About The Home Depot

The Home Depot is the world’s largest home improvement specialty retailer, with 2,292 retail stores in all 50 states, the District of Columbia, Puerto Rico, U.S. Virgin Islands, Guam, 10 Canadian provinces and Mexico. In fiscal 2019, The Home Depot had sales of $110.2 billion and earnings of $11.2 billion. The Company employs more than 400,000 associates. The Home Depot’s stock is traded on the New York Stock Exchange (NYSE: HD) and is included in the Dow Jones industrial average and Standard & Poor’s 500 index.

Logo – https://mma.prnewswire.com/media/118058/the_home_depot_logo.jpg

SOURCE HOME DEPOT

The Home Depot to Hold Virtual Annual Meeting of Shareholders

ATLANTA, April 21, 2020 /PRNewswire-HISPANIC PR WIRE/ — The Home Depot®, the world’s largest home improvement retailer, today announced that it will hold its 2020 Annual Meeting of Shareholders virtually due to the public health impact of the COVID-19 pandemic and to support the health and well-being of its shareholders, associates, directors, and the community.

<img id="prnejpg8e19left" title="The Home…

ATLANTA, April 21, 2020 /PRNewswire-HISPANIC PR WIRE/ — The Home Depot®, the world’s largest home improvement retailer, today announced that it will hold its 2020 Annual Meeting of Shareholders virtually due to the public health impact of the COVID-19 pandemic and to support the health and well-being of its shareholders, associates, directors, and the community.

The Home Depot logo.

The Annual Meeting will be held on the same date and time as originally scheduled: Thursday, May 21, 2020 at 9:00 a.m., Eastern Time. Online access to the meeting will begin at 8:45 a.m., Eastern Time. Shareholders will not be able to attend the meeting in person. Any updates will be posted at https://ir.homedepot.com/shareholder-services/annual-meeting prior to the meeting date.

The Home Depot also announced that it plans to return to a physical, in-person meeting format next year for its 2021 Annual Meeting of Shareholders.

Attending the Virtual Annual Meeting

Shareholders of record as of the close of business on March 23, 2020, the record date, or «street name» holders that hold a legal proxy, broker’s proxy card or voting information form provided by their bank, broker or nominee, can attend the meeting by accessing www.virtualshareholdermeeting.com/HD2020 and entering the 16-digit control number included in the proxy materials previously received. Please note that the www.virtualshareholdermeeting.com/HD2020 web page will not be active until approximately two weeks before the meeting date.

Asking Questions

Shareholders may submit questions in two ways. If they wish to submit a question before the meeting, then beginning on April 22, 2020, until the meeting, they may log into www.proxyvote.com and enter their 16-digit control number. Once past the login screen, click on «Question for Management,» type in the question, and click «Submit.» Alternatively, shareholders will be able to submit questions live during the meeting by accessing the meeting at www.virtualshareholdermeeting.com/HD2020 using their 16-digit control number, typing the question into the «Ask a Question» field, and clicking submit.

Only questions pertinent to meeting matters will be answered during the meeting, subject to time constraints. Questions regarding personal matters, including those related to employment, product or service issues, or suggestions for product innovations, are not pertinent to meeting matters and therefore will not be answered. Questions that are substantially similar may be grouped and answered together to avoid repetition.

If we are unable to answer your question during the meeting due to time constraints, you are encouraged to contact The Home Depot Investor Relations department at investor_relations@homedepot.com.

Voting Shares at the Virtual Meeting

Shareholders who have not voted their shares prior to the meeting or who wish to change their vote will be able to vote their shares electronically at the meeting by clicking «Vote Here» on the meeting website.

Whether or not shareholders plan to attend the meeting, they are encouraged to vote their shares prior to the meeting by one of the methods described in the proxy materials previously provided. Shareholders may continue to use the proxy materials they previously received to vote their shares in connection with the meeting.

Shareholders who have already voted do not need to vote again.

Accessing the List of Shareholders Entitled to Vote

An electronic list of the shareholders of record as of the record date will be available for examination by shareholders at www.virtualshareholdermeeting.com/HD2020 during the meeting, along with the proxy materials for the meeting. Shareholders will need to enter their 16-digit control number to access the shareholder list. Information on how to access the list of shareholders from May 11, 2020 until the meeting is available at https://ir.homedepot.com/shareholder-services/annual-meeting.

Attending the Virtual Meeting as a Guest

If you do not have a 16-digit control number, you may still attend the meeting as a guest in listen-only mode. To attend as a guest, please access www.virtualshareholdermeeting.com/HD2020 and enter the information requested on the screen to register as a guest. Please note that you will not have the ability to ask questions, vote or examine the list of shareholders during the meeting if you participate as a guest.

About The Home Depot

The Home Depot is the world’s largest home improvement specialty retailer, with 2,292 retail stores in all 50 states, the District of Columbia, Puerto Rico, U.S. Virgin Islands, Guam, 10 Canadian provinces and Mexico. In fiscal 2019, The Home Depot had sales of $110.2 billion and earnings of $11.2 billion. The Company employs more than 400,000 associates. The Home Depot’s stock is traded on the New York Stock Exchange (NYSE: HD) and is included in the Dow Jones industrial average and Standard & Poor’s 500 index.

Logo – https://mma.prnewswire.com/media/118058/the_home_depot_logo.jpg

SOURCE HOME DEPOT

SBS Entertainment Announces ‘Mi Casa Es Tu Casa Live Music Series’

MIAMI, April 21, 2020 /PRNewswire-HISPANIC PR WIRE/ — SBS Entertainment, the entertainment division of Spanish Broadcasting System, Iinc. (SBS), a leading Hispanic media company, today announced Mi Casa Es Tu Casa Live Music Series, launching Friday, April 24. The series will feature one-hour of commercial-free live music and positive messages by top Latin artists across some of SBS’s leading regional Mexican and Latin urban radio stations in key Hispanic…

MIAMI, April 21, 2020 /PRNewswire-HISPANIC PR WIRE/ — SBS Entertainment, the entertainment division of Spanish Broadcasting System, Iinc. (SBS), a leading Hispanic media company, today announced Mi Casa Es Tu Casa Live Music Series, launching Friday, April 24. The series will feature one-hour of commercial-free live music and positive messages by top Latin artists across some of SBS’s leading regional Mexican and Latin urban radio stations in key Hispanic markets and LaMusica app. The star-studded line-up includes Pitbull and Calibre 50, who will kick-off the series respectively, as well as Christian Nodal, Maluma, Natti Natasha, Gerardo Ortiz, Banda MS, Sebastian Yatra and many others.

«Mi Casa Es Tu Casa Live Music Series was designed in partnership with some of the biggest names in Latin music to entertain and encourage our listeners during this unprecedented time,» said Alessandra Alarcón, President of SBS Entertainment. «We’re making the pledge to be there for the Hispanic community every step of the way, not only by keeping them informed with the latest news and preparedness tips, but by also delivering our unparalleled live music experiences right to their favorite SBS radio stations and the LaMusica app.»

The spread of the coronavirus has disproportionately affected many Hispanics across the nation, however, this coveted community continues to tune-in to their favorite radio stations and are leaning on radio personalities for support. According to Nielsen, 83% of American adults report spending the same or more time with radio as a result of the COVID-19 outbreak. 62% of Hispanics agree that radio is a good source of information and 44% agree that having access to radio (on-air or online) has helped them deal with the COVID-19 (coronavirus) outbreak. *

«We’ve seen a slight uptick in listenership across most of our SBS audio stations and digital platforms since the beginning of the pandemic which is a testament of Nielsen’s recent COVID-19 study,» added Alarcón. «This is precisely why we’re exclusively airing the Mi Casa Es Tu Casa Live Music Series across our leading audio platforms. Our goal is to reach and support as many Hispanics as possible. No matter if they are listening to us at home, in their car or at work, we want to brighten up their day with the music and artists they love.»

Mi Casa Es Tu Casa Live Music Series Dates
All concerts will take place at 7 p.m. ET/CDT/PT and will also be streamed on the LaMusica App

DATE

ARTIST

MARKET & PARTICIPATING SBS RADIO STATION

4/24/20

Pitbull

New York – WSKQ 97.9 FM; Miami – WXDJ 106.7 FM; Los Angeles – KXOL 96.3 FM

4/24/20

Calibre 50

Los Angeles – KLAX 97.9 FM; San Francisco – KRZZ 93.3 FM; Chicago – WLEY 107.9 FM

5/1/20

Maluma

New York – WSKQ 97.9 FM; Miami – WXDJ 106.7 FM; Los Angeles – KXOL 96.3 FM- Puerto Rico – WMEG- 106.9FM

5/1/20

Banda Carnaval

Los Angeles – KLAX 97.9 FM; San Francisco – KRZZ 93.3 FM; Chicago – WLEY 107.9 FM

5/8/20

Pancho Barraza

Los Angeles – KLAX 97.9 FM; San Francisco – KRZZ 93.3 FM; Chicago – WLEY 107.9 FM

5/14/20

Natti Natasha

New York – WSKQ 97.9 FM; Miami – WXDJ 106.7 FM; Los Angeles – KXOL 96.3 FM – Puerto Rico – WMEG- 106.9 FM

5/15/20

Gerardo Ortiz

Los Angeles – KLAX 97.9 FM; San Francisco – KRZZ 93.3 FM; Chicago – WLEY 107.9 FM

5/21/20

Reik

New York – WSKQ 97.9 FM; Miami – WXDJ 106.7 FM; Los Angeles – KXOL 96.3 FM – Puerto Rico – WMEG- 106.9FM

5/22/20

Christian Nodal

Los Angeles – KLAX 97.9 FM; San Francisco – KRZZ 93.3 FM; Chicago – WLEY 107.9 FM

5/28/20

Sebastian Yatra

New York – WSKQ 97.9 FM; Miami – WXDJ 106.7 FM; Los Angeles – KXOL 96.3 FM – Puerto Rico – WMEG- 106.9 FM

5/29/20

Primavera

Los Angeles – KLAX 97.9 FM; San Francisco – KRZZ 93.3 FM; Chicago – WLEY 107.9 FM

6/5/20

Espinoza Paz

Los Angeles – KLAX 97.9 FM; San Francisco – KRZZ 93.3 FM; Chicago – WLEY 107.9 FM

6/12/20

Banda MS

Los Angeles – KLAX 97.9 FM; San Francisco – KRZZ 93.3 FM; Chicago – WLEY 107.9 FM

*Source: Custom Nielsen study conducted March 20-22 via an online survey, based on a weighted sample of 1000 adults 18+

LATIN MUSIC HAPPENS HERE AT SPANISH BROADCASTING SYSTEM

About Spanish Broadcasting System, Inc.
Spanish Broadcasting System, Inc. owns and operates 17 radio stations located in the top U.S. Hispanic markets of New York, Los Angeles, Miami, Chicago, San Francisco and Puerto Rico, airing the Spanish Tropical, Regional Mexican, Spanish Adult Contemporary, Top 40 and Latin Rhythmic format genres. SBS also operates AIRE Radio Networks, a national radio platform which creates, distributes and markets leading Spanish-language radio programming to over 250 affiliated stations reaching 95% of the U.S. Hispanic audience. SBS also owns MegaTV, a television operation with over-the-air, cable and satellite distribution and affiliates throughout the U.S. and Puerto Rico. SBS also produces live concerts and events and owns multiple bilingual websites, including LaMusica, a mobile app providing content related to Latin music, entertainment, news and culture. For more information, visit us online at www.spanishbroadcasting.com.

MEDIA CONTACT SBS:

Vladimir Gomez
vgomez@sbscorporate.com  
(786) 470-1644

SOURCE Spanish Broadcasting System, Inc.

SBS Entertainment Announces ‘Mi Casa Es Tu Casa Live Music Series’

MIAMI, April 21, 2020 /PRNewswire-HISPANIC PR WIRE/ — SBS Entertainment, the entertainment division of Spanish Broadcasting System, Iinc. (SBS), a leading Hispanic media company, today announced Mi Casa Es Tu Casa Live Music Series, launching Friday, April 24. The series will feature one-hour of commercial-free live music and positive messages by top Latin artists across some of SBS’s leading regional Mexican and Latin urban radio stations in key Hispanic…

MIAMI, April 21, 2020 /PRNewswire-HISPANIC PR WIRE/ — SBS Entertainment, the entertainment division of Spanish Broadcasting System, Iinc. (SBS), a leading Hispanic media company, today announced Mi Casa Es Tu Casa Live Music Series, launching Friday, April 24. The series will feature one-hour of commercial-free live music and positive messages by top Latin artists across some of SBS’s leading regional Mexican and Latin urban radio stations in key Hispanic markets and LaMusica app. The star-studded line-up includes Pitbull and Calibre 50, who will kick-off the series respectively, as well as Christian Nodal, Maluma, Natti Natasha, Gerardo Ortiz, Banda MS, Sebastian Yatra and many others.

«Mi Casa Es Tu Casa Live Music Series was designed in partnership with some of the biggest names in Latin music to entertain and encourage our listeners during this unprecedented time,» said Alessandra Alarcón, President of SBS Entertainment. «We’re making the pledge to be there for the Hispanic community every step of the way, not only by keeping them informed with the latest news and preparedness tips, but by also delivering our unparalleled live music experiences right to their favorite SBS radio stations and the LaMusica app.»

The spread of the coronavirus has disproportionately affected many Hispanics across the nation, however, this coveted community continues to tune-in to their favorite radio stations and are leaning on radio personalities for support. According to Nielsen, 83% of American adults report spending the same or more time with radio as a result of the COVID-19 outbreak. 62% of Hispanics agree that radio is a good source of information and 44% agree that having access to radio (on-air or online) has helped them deal with the COVID-19 (coronavirus) outbreak. *

«We’ve seen a slight uptick in listenership across most of our SBS audio stations and digital platforms since the beginning of the pandemic which is a testament of Nielsen’s recent COVID-19 study,» added Alarcón. «This is precisely why we’re exclusively airing the Mi Casa Es Tu Casa Live Music Series across our leading audio platforms. Our goal is to reach and support as many Hispanics as possible. No matter if they are listening to us at home, in their car or at work, we want to brighten up their day with the music and artists they love.»

Mi Casa Es Tu Casa Live Music Series Dates
All concerts will take place at 7 p.m. ET/CDT/PT and will also be streamed on the LaMusica App

DATE

ARTIST

MARKET & PARTICIPATING SBS RADIO STATION

4/24/20

Pitbull

New York – WSKQ 97.9 FM; Miami – WXDJ 106.7 FM; Los Angeles – KXOL 96.3 FM

4/24/20

Calibre 50

Los Angeles – KLAX 97.9 FM; San Francisco – KRZZ 93.3 FM; Chicago – WLEY 107.9 FM

5/1/20

Maluma

New York – WSKQ 97.9 FM; Miami – WXDJ 106.7 FM; Los Angeles – KXOL 96.3 FM- Puerto Rico – WMEG- 106.9FM

5/1/20

Banda Carnaval

Los Angeles – KLAX 97.9 FM; San Francisco – KRZZ 93.3 FM; Chicago – WLEY 107.9 FM

5/8/20

Pancho Barraza

Los Angeles – KLAX 97.9 FM; San Francisco – KRZZ 93.3 FM; Chicago – WLEY 107.9 FM

5/14/20

Natti Natasha

New York – WSKQ 97.9 FM; Miami – WXDJ 106.7 FM; Los Angeles – KXOL 96.3 FM – Puerto Rico – WMEG- 106.9 FM

5/15/20

Gerardo Ortiz

Los Angeles – KLAX 97.9 FM; San Francisco – KRZZ 93.3 FM; Chicago – WLEY 107.9 FM

5/21/20

Reik

New York – WSKQ 97.9 FM; Miami – WXDJ 106.7 FM; Los Angeles – KXOL 96.3 FM – Puerto Rico – WMEG- 106.9FM

5/22/20

Christian Nodal

Los Angeles – KLAX 97.9 FM; San Francisco – KRZZ 93.3 FM; Chicago – WLEY 107.9 FM

5/28/20

Sebastian Yatra

New York – WSKQ 97.9 FM; Miami – WXDJ 106.7 FM; Los Angeles – KXOL 96.3 FM – Puerto Rico – WMEG- 106.9 FM

5/29/20

Primavera

Los Angeles – KLAX 97.9 FM; San Francisco – KRZZ 93.3 FM; Chicago – WLEY 107.9 FM

6/5/20

Espinoza Paz

Los Angeles – KLAX 97.9 FM; San Francisco – KRZZ 93.3 FM; Chicago – WLEY 107.9 FM

6/12/20

Banda MS

Los Angeles – KLAX 97.9 FM; San Francisco – KRZZ 93.3 FM; Chicago – WLEY 107.9 FM

*Source: Custom Nielsen study conducted March 20-22 via an online survey, based on a weighted sample of 1000 adults 18+

LATIN MUSIC HAPPENS HERE AT SPANISH BROADCASTING SYSTEM

About Spanish Broadcasting System, Inc.
Spanish Broadcasting System, Inc. owns and operates 17 radio stations located in the top U.S. Hispanic markets of New York, Los Angeles, Miami, Chicago, San Francisco and Puerto Rico, airing the Spanish Tropical, Regional Mexican, Spanish Adult Contemporary, Top 40 and Latin Rhythmic format genres. SBS also operates AIRE Radio Networks, a national radio platform which creates, distributes and markets leading Spanish-language radio programming to over 250 affiliated stations reaching 95% of the U.S. Hispanic audience. SBS also owns MegaTV, a television operation with over-the-air, cable and satellite distribution and affiliates throughout the U.S. and Puerto Rico. SBS also produces live concerts and events and owns multiple bilingual websites, including LaMusica, a mobile app providing content related to Latin music, entertainment, news and culture. For more information, visit us online at www.spanishbroadcasting.com.

MEDIA CONTACT SBS:

Vladimir Gomez
vgomez@sbscorporate.com  
(786) 470-1644

SOURCE Spanish Broadcasting System, Inc.

SBS Entertainment Announces ‘Mi Casa Es Tu Casa Live Music Series’

MIAMI, April 21, 2020 /PRNewswire/ — SBS Entertainment, the entertainment division of Spanish Broadcasting System, Iinc. (SBS), a leading Hispanic media company, today announced Mi Casa Es Tu Casa Live Music Series, launching Friday, April 24. The series will feature one-hour of commercial-free live music and positive messages by top Latin artists across some of SBS’s leading regional Mexican and Latin urban radio stations in key Hispanic markets and…

MIAMI, April 21, 2020 /PRNewswire/ — SBS Entertainment, the entertainment division of Spanish Broadcasting System, Iinc. (SBS), a leading Hispanic media company, today announced Mi Casa Es Tu Casa Live Music Series, launching Friday, April 24. The series will feature one-hour of commercial-free live music and positive messages by top Latin artists across some of SBS’s leading regional Mexican and Latin urban radio stations in key Hispanic markets and LaMusica app. The star-studded line-up includes Pitbull and Calibre 50, who will kick-off the series respectively, as well as Christian Nodal, Maluma, Natti Natasha, Gerardo Ortiz, Banda MS, Sebastian Yatra and many others.

«Mi Casa Es Tu Casa Live Music Series was designed in partnership with some of the biggest names in Latin music to entertain and encourage our listeners during this unprecedented time,» said Alessandra Alarcón, President of SBS Entertainment. «We’re making the pledge to be there for the Hispanic community every step of the way, not only by keeping them informed with the latest news and preparedness tips, but by also delivering our unparalleled live music experiences right to their favorite SBS radio stations and the LaMusica app.»

The spread of the coronavirus has disproportionately affected many Hispanics across the nation, however, this coveted community continues to tune-in to their favorite radio stations and are leaning on radio personalities for support. According to Nielsen, 83% of American adults report spending the same or more time with radio as a result of the COVID-19 outbreak. 62% of Hispanics agree that radio is a good source of information and 44% agree that having access to radio (on-air or online) has helped them deal with the COVID-19 (coronavirus) outbreak. *

«We’ve seen a slight uptick in listenership across most of our SBS audio stations and digital platforms since the beginning of the pandemic which is a testament of Nielsen’s recent COVID-19 study,» added Alarcón. «This is precisely why we’re exclusively airing the Mi Casa Es Tu Casa Live Music Series across our leading audio platforms. Our goal is to reach and support as many Hispanics as possible. No matter if they are listening to us at home, in their car or at work, we want to brighten up their day with the music and artists they love.»

Mi Casa Es Tu Casa Live Music Series Dates
All concerts will take place at 7 p.m. ET/CDT/PT and will also be streamed on the LaMusica App

DATE

ARTIST

MARKET & PARTICIPATING SBS RADIO STATION

4/24/20

Pitbull

New York – WSKQ 97.9 FM; Miami – WXDJ 106.7 FM; Los Angeles – KXOL 96.3 FM

4/24/20

Calibre 50

Los Angeles – KLAX 97.9 FM; San Francisco – KRZZ 93.3 FM; Chicago – WLEY 107.9 FM

5/1/20

Maluma

New York – WSKQ 97.9 FM; Miami – WXDJ 106.7 FM; Los Angeles – KXOL 96.3 FM- Puerto Rico – WMEG- 106.9FM

5/1/20

Banda Carnaval

Los Angeles – KLAX 97.9 FM; San Francisco – KRZZ 93.3 FM; Chicago – WLEY 107.9 FM

5/8/20

Pancho Barraza

Los Angeles – KLAX 97.9 FM; San Francisco – KRZZ 93.3 FM; Chicago – WLEY 107.9 FM

5/14/20

Natti Natasha

New York – WSKQ 97.9 FM; Miami – WXDJ 106.7 FM; Los Angeles – KXOL 96.3 FM – Puerto Rico – WMEG- 106.9 FM

5/15/20

Gerardo Ortiz

Los Angeles – KLAX 97.9 FM; San Francisco – KRZZ 93.3 FM; Chicago – WLEY 107.9 FM

5/21/20

Reik

New York – WSKQ 97.9 FM; Miami – WXDJ 106.7 FM; Los Angeles – KXOL 96.3 FM – Puerto Rico – WMEG- 106.9FM

5/22/20

Christian Nodal

Los Angeles – KLAX 97.9 FM; San Francisco – KRZZ 93.3 FM; Chicago – WLEY 107.9 FM

5/28/20

Sebastian Yatra

New York – WSKQ 97.9 FM; Miami – WXDJ 106.7 FM; Los Angeles – KXOL 96.3 FM – Puerto Rico – WMEG- 106.9 FM

5/29/20

Primavera

Los Angeles – KLAX 97.9 FM; San Francisco – KRZZ 93.3 FM; Chicago – WLEY 107.9 FM

6/5/20

Espinoza Paz

Los Angeles – KLAX 97.9 FM; San Francisco – KRZZ 93.3 FM; Chicago – WLEY 107.9 FM

6/12/20

Banda MS

Los Angeles – KLAX 97.9 FM; San Francisco – KRZZ 93.3 FM; Chicago – WLEY 107.9 FM

*Source: Custom Nielsen study conducted March 20-22 via an online survey, based on a weighted sample of 1000 adults 18+

LATIN MUSIC HAPPENS HERE AT SPANISH BROADCASTING SYSTEM

About Spanish Broadcasting System, Inc.
Spanish Broadcasting System, Inc. owns and operates 17 radio stations located in the top U.S. Hispanic markets of New York, Los Angeles, Miami, Chicago, San Francisco and Puerto Rico, airing the Spanish Tropical, Regional Mexican, Spanish Adult Contemporary, Top 40 and Latin Rhythmic format genres. SBS also operates AIRE Radio Networks, a national radio platform which creates, distributes and markets leading Spanish-language radio programming to over 250 affiliated stations reaching 95% of the U.S. Hispanic audience. SBS also owns MegaTV, a television operation with over-the-air, cable and satellite distribution and affiliates throughout the U.S. and Puerto Rico. SBS also produces live concerts and events and owns multiple bilingual websites, including LaMusica, a mobile app providing content related to Latin music, entertainment, news and culture. For more information, visit us online at www.spanishbroadcasting.com.

MEDIA CONTACT SBS:

Vladimir Gomez
vgomez@sbscorporate.com  
(786) 470-1644

Cision View original content:http://www.prnewswire.com/news-releases/sbs-entertainment-announces-mi-casa-es-tu-casa-live-music-series-301044644.html

SOURCE Spanish Broadcasting System, Inc.

Kellogg Latinoamérica dona $1 millón de dólares para programas de alimentación y COVID19

QUERETARO, México, 21 de abril de 2020 /PRNewswire/ — A medida que evoluciona la pandemia de COVID-19, las familias en nuestras comunidades deben permanecer en sus hogares para reducir el riesgo de propagación del virus. Las escuelas y un número cada vez mayor de empresas permanecen cerradas y muchos de nuestros vecinos vulnerables necesitan alimentos.

Es por eso que Kellogg Latinoamérica anuncia la donación de $1 millón de dólares en efectivo y alimentos, para garantizar que…

QUERETARO, México, 21 de abril de 2020 /PRNewswire/ — A medida que evoluciona la pandemia de COVID-19, las familias en nuestras comunidades deben permanecer en sus hogares para reducir el riesgo de propagación del virus. Las escuelas y un número cada vez mayor de empresas permanecen cerradas y muchos de nuestros vecinos vulnerables necesitan alimentos.

Es por eso que Kellogg Latinoamérica anuncia la donación de $1 millón de dólares en efectivo y alimentos, para garantizar que las familias, y en particular los niños, continúen teniendo acceso a los mismos. Esto significará la entrega de aproximadamente 25 millones de porciones de alimento, entre otros recursos.

Estos recursos llegarán a la población que más lo necesita a través del trabajo de aliados clave, incluidos United Way y Global FoodBanking Network, quienes, a través de su red de bancos de alimentos en Latinoamérica, asegurarán que la comida llegue a quienes más la necesitan.

«Nuestro propósito es continuar ayudando a garantizar mejores días para quienes más lo necesitan, proporcionando un mayor acceso a los alimentos. Hoy, como sociedad, enfrentamos un gran desafío como resultado de COVID-19, por lo que debemos contribuir y actuar juntos», dijo Nicolás Amaya, Presidente de Kellogg Latinoamérica. «Como empresa, tenemos la responsabilidad social de suministrar a nuestros consumidores nuestros alimentos cuando más los necesitan, pero también ampliamos este compromiso a las comunidades más vulnerables. Apoyamos y reconocemos el trabajo de nuestros aliados sociales, agregó. Juntos, podemos mejorar las cosas para aquellos que más lo necesitan durante este momento difícil.»

Si desea unirse y apoyar a las familias que más lo necesitan, por favor haga clic aquí para obtener más información sobre las necesidades más frecuentes en el banco de alimentos de su localidad.

HAGA CLIC AQUÍ PARA HABLAR CON KELLOGG

Esta acción de Kellogg para Latinoamérica es complementaria al reciente anuncio hecho por la compañía, a través del cual su plataforma «Mejores Días» impulsa el desarrollo comunitario y el combate del hambre. En ese anuncio comprometió recursos por 7.5 millones de dólares para programas de ayuda alimentaria por COVID-19 en el mundo.

#HagamosFamilia

#MejoresDíasKellogg

Para cualquier inquietud, por favor contacte a: oscar.campos@porternovelli.com

Mejores Días logo (PRNewsfoto/Kellogg Latinoamérica)

Logo – https://mma.prnewswire.com/media/1158106/Mejores_Dias.jpg 

 

 

FUENTE Kellogg Latinoamérica